Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Robert E. Bristow

Department of Gynecology

The Kelly Gynecologic Oncology Service

The Sidney Kimmel Comprehensive Cancer Center

The Johns Hopkins Medical Institutions

USA

[email]@jhmi.edu

Name/email consistency: high

[Claim this account]

Affiliation

Department of Gynecology, The Kelly Gynecologic Oncology Service, The Sidney Kimmel Comprehensive Cancer Center, The Johns Hopkins Medical Institutions, USA. 1999 - 2009

References

Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis. Bristow, R.E., Puri, I., Chi, D.S. Gynecol. Oncol. (2009) [Pubmed]
Advanced cytoreductive surgery in gynecologic oncology. Bristow, R.E. Gynecol. Oncol. (2009) [Pubmed]
Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Bristow, R.E., Eisenhauer, E.L., Santillan, A., Chi, D.S. Gynecol. Oncol. (2007) [Pubmed]
Intraperitoneal cisplatin and paclitaxel versus intravenous carboplatin and paclitaxel chemotherapy for Stage III ovarian cancer: a cost-effectiveness analysis. Bristow, R.E., Santillan, A., Salani, R., Diaz-Montes, T.P., Giuntoli, R.L., Meisner, B.C., Armstrong, D.K., Frick, K.D. Gynecol. Oncol. (2007) [Pubmed]
Prevention of adhesion formation after radical hysterectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier: a cost-effectiveness analysis. Bristow, R.E., Santillan, A., Diaz-Montes, T.P., Gardner, G.J., Giuntoli, R.L., Peeler, S.T. Gynecol. Oncol. (2007) [Pubmed]
Centralization of care for patients with advanced-stage ovarian cancer: a cost-effectiveness analysis. Bristow, R.E., Santillan, A., Diaz-Montes, T.P., Gardner, G.J., Giuntoli, R.L., Meisner, B.C., Frick, K.D., Armstrong, D.K. Cancer (2007) [Pubmed]
Impact of surgeon specialty on ovarian-conserving surgery in young females with an adnexal mass. Bristow, R.E., Nugent, A.C., Zahurak, M.L., Khouzhami, V., Fox, H.E. J. Adolesc. Health (2006) [Pubmed]
Cost-effectiveness of routine vaginal cytology for endometrial cancer surveillance. Bristow, R.E., Purinton, S.C., Santillan, A., Diaz-Montes, T.P., Gardner, G.J., Giuntoli, R.L. Gynecol. Oncol. (2006) [Pubmed]
Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer: a meta-analysis. Bristow, R.E., Chi, D.S. Gynecol. Oncol. (2006) [Pubmed]
Salvage cytoreductive surgery for recurrent endometrial cancer. Bristow, R.E., Santillan, A., Zahurak, M.L., Gardner, G.J., Giuntoli, R.L., Armstrong, D.K. Gynecol. Oncol. (2006) [Pubmed]
Combined PET/CT for detecting recurrent ovarian cancer limited to retroperitoneal lymph nodes. Bristow, R.E., Giuntoli, R.L., Pannu, H.K., Schulick, R.D., Fishman, E.K., Wahl, R.L. Gynecol. Oncol. (2005) [Pubmed]
Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier. Bristow, R.E., Montz, F.J. Gynecol. Oncol. (2005) [Pubmed]
Ovarian cancer surgery in Maryland: volume-based access to care. Bristow, R.E., Zahurak, M.L., del Carmen, M.G., Gordon, T.A., Fox, H.E., Trimble, E.L., Montz, F.J. Gynecol. Oncol. (2004) [Pubmed]
Clinically occult recurrent ovarian cancer: patient selection for secondary cytoreductive surgery using combined PET/CT. Bristow, R.E., del Carmen, M.G., Pannu, H.K., Cohade, C., Zahurak, M.L., Fishman, E.K., Wahl, R.L., Montz, F.J. Gynecol. Oncol. (2003) [Pubmed]
FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Bristow, R.E., Zahurak, M.L., Alexander, C.J., Zellars, R.C., Montz, F.J. Int. J. Gynecol. Cancer (2003) [Pubmed]
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. Bristow, R.E., Tomacruz, R.S., Armstrong, D.K., Trimble, E.L., Montz, F.J. J. Clin. Oncol. (2002) [Pubmed]
Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer. Bristow, R.E., Simpkins, F., Pannu, H.K., Fishman, E.K., Montz, F.J. Gynecol. Oncol. (2002) [Pubmed]
Micropapillary serous ovarian carcinoma: surgical management and clinical outcome. Bristow, R.E., Gossett, D.R., Shook, D.R., Zahurak, M.L., Tomacruz, R.S., Armstrong, D.K., Montz, F.J. Gynecol. Oncol. (2002) [Pubmed]
Recurrent micropapillary serous ovarian carcinoma. Bristow, R.E., Gossett, D.R., Shook, D.R., Zahurak, M.L., Tomacruz, R.S., Armstrong, D.K., Montz, F.J. Cancer (2002) [Pubmed]
Leiomyomatosis peritonealis disseminata and ovarian Brenner tumor associated with tamoxifen use. Bristow, R.E., Montz, F.J. Int. J. Gynecol. Cancer (2001) [Pubmed]
Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Bristow, R.E., Montz, F.J. Gynecol. Oncol. (2001) [Pubmed]
Ablation of metastatic ovarian carcinoma with the argon beam coagulator: pathologic analysis of tumor destruction. Bristow, R.E., Smith Sehdev, A.E., Kaufman, H.S., Montz, F.J. Gynecol. Oncol. (2001) [Pubmed]
Surgical standards in the management of ovarian cancer. Bristow, R.E. Curr. Opin. Oncol (2000) [Pubmed]
A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Bristow, R.E., Duska, L.R., Lambrou, N.C., Fishman, E.K., O'Neill, M.J., Trimble, E.L., Montz, F.J. Cancer (2000) [Pubmed]
Endometrial cancer. Bristow, R.E. Curr. Opin. Oncol (1999) [Pubmed]

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.